CONTRIBUTION OF THE GENETIC STATUS OF OXIDATIVE-METABOLISM TO VARIABILITY IN THE PLASMA-CONCENTRATIONS OF BETA-ADRENOCEPTOR BLOCKING-AGENTS

被引:24
作者
DAYER, P [1 ]
BALANT, L [1 ]
KUPFER, A [1 ]
COURVOISIER, F [1 ]
FABRE, J [1 ]
机构
[1] UNIV GENEVA,DEPT MED,MED POLYCLIN,CH-1211 GENEVA 4,SWITZERLAND
关键词
D O I
10.1007/BF00607090
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:797 / 799
页数:3
相关论文
共 27 条
  • [1] ALVAN G, 1982, LANCET, V1, P333
  • [2] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
    BERTILSSON, L
    DENGLER, HJ
    EICHELBAUM, M
    SCHULZ, HU
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
  • [3] DEFECTIVE HYDROXYLATION OF BUFURALOL ASSOCIATED WITH SIDE-EFFECTS OF THE DRUG IN POOR METABOLIZERS
    DAYER, P
    KUBLI, A
    KUPFER, A
    COURVOISIER, F
    BALANT, L
    FABRE, J
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) : 750 - 752
  • [4] THE GENETIC-CONTROL OF BUFURALOL METABOLISM IN MAN
    DAYER, P
    BALANT, L
    COURVOISIER, F
    KUPFER, A
    KUBLI, A
    GORGIA, A
    FABRE, J
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1982, 7 (01) : 73 - 77
  • [5] DENGLER HJ, 1977, ARZNEIMITTEL-FORSCH, V27-2, P1836
  • [6] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
    EICHELBAUM, M
    SPANNBRUCKER, N
    STEINCKE, B
    DENGLER, HJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
  • [7] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
    EICHELBAUM, M
    BERTILSSON, L
    SAWE, J
    ZEKORN, C
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
  • [8] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
  • [9] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
    EVANS, DAP
    MAHGOUB, A
    SLOAN, TP
    IDLE, JR
    SMITH, RL
    [J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
  • [10] FRANCIS RJ, 1976, EUROP J DRUG METAB P, V2, P113